Tate S et al. – In the current study it was shown that outcomes improved after implementing aggressive surgery for advanced ovarian cancer.

Methods

• 106 patients with stage III/IV ovarian, fallopian, and peritoneal cancer undergoing elective aggressive surgery were studied.

Results

• The median progression-free and overall survival rates increased from 14.6 and 38.1?months before implementation of aggressive surgery, respectively, to 25.0 and 68.5?months after implementation, respectively.
• Complete resection was achieved in 83 of 106 patients, and the surgical complexity score was high (>8) in 61 patients.
• There were no mortality within 12?weeks of surgery.